Back to Studies

P1112 / Monoclonal Antibody PK Study

Open-Label, Dose-Escalating, Phase I Study to Determine Safety and
Pharmacokinetic Parameters of Subcutaneous (SC) VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants

Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...